The nuclear imaging sector in Portugal is witnessing significant growth, driven by a hybrid healthcare model that merges universal public coverage with a burgeoning private sector. The Serviço Nacional de Saúde (SNS), which is financed through general taxation, provides extensive access to healthcar ...

The market for laparoscopic energy systems in Portugal is being propelled by a healthcare environment that prioritizes precision, efficiency, and patient-focused minimally invasive surgical techniques. The Portuguese healthcare system is increasingly embracing advanced surgical technologies aimed at ...

Portugal's air cargo demand is largely influenced by its exports of perishable goods. The country is a key exporter of fresh fish, fruits, and vegetables, particularly berries and early-season crops, which are transported by air to northern European markets to maintain freshness and achieve higher p ...

Portugal's market for dialysis concentrates and solutions is strong, bolstered by its universal public healthcare system, the Servico Nacional de Saude (SNS). This system ensures that all residents have access to essential medical treatments, including dialysis. The market is significantly influence ...

Cimentos de Portugal SGPS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc ...

The market for computed tomography devices in Portugal is supported by a well-regarded healthcare system that combines universal public coverage through the Serviço Nacional de Saúde (SNS) with a growing private sector. This dual structure, coupled with rising clinical demand, is driving the adoptio ...

Portugal data center colocation market is expected to grow at a CAGR of 26.73% from 2024 to 2030. Portugal has around 17 operational colocation data centers as of December 2024, and this number is expected to increase over time, as several existing and new companies have planned investments in the c ...

There is expected to be muted current value growth in paediatric consumer health in Portugal in 2025. That being said, there continues to be product innovation, with a focus on formats, with more prevalence of chewable tablets and gummies. Paediatric cough, cold and allergy remedies are expected to ...

Wound care is expected to register muted current value and volume growth in Portugal in 2025. All the same, wound care received a boost from the electricity blackout that affected Portugal and Spain in April 2025, as the emergency highlighted the importance of having first aid supplies always at han ...

Sports nutrition is expected to continue to register healthy current value growth in 2025. That being said, value growth is lower than previous years, as increasing competition lowers prices. In particular, supermarkets retailers such as Continente and Pingo Doce are developing sports nutrition lin ...

Dietary supplements is expected to register positive current value and volume growth in Portugal in 2025. Dietary supplements are seen as a means of preventative care and have evolved significantly over the review period to include more effective and improved offerings and consumers also understand ...

Cough, cold and allergy (hay fever) remedies is expected to register moderate current value growth in Portugal in 2025. New viruses that are resistant to antibiotics support value sales. In addition, an ageing population which takes longer to recover from colds and coughs, also supports value sales. ...

Consumer health in Portugal is expected to register healthy current value growth in 2025. An ageing population supports value sales, as many health issues affect older people more seriously. In addition, with the public health system under increasing pressure, it is becoming more difficult to access ...

Analgesics is expected to register moderate current value growth in Portugal in 2025. An ageing population, which is leading to a higher prevalence of chronic pain conditions, as well as increasing difficulties in assessing medical care, support value sales. Systemic analgesics is expected to regist ...

Weight management and wellbeing is expected to register muted current value growth in Portugal in 2025. That being said, value vales are supported by a growing obese population and a realisation of the health implications of being overweight. However, one factors that is having a negative impact is ...

Digestive remedies is expected to register moderate current value growth in Portugal in 2025. An ageing population, as well as other factors such as increasing stress levels and obesity, continue to support value sales. Consumers are also more aware of the importance of digestion, stemming from a gr ...

Herbal/traditional product is expected to register healthy current value growth in 2025. A growing consumer preference for natural therapies, concern in terms of side effects from chemical components and a desire for self-care and preventative health measures, support value sales. In 2025, herbal/tr ...

Eye care is expected to register positive current value and volume growth in Portugal in 2025, though growth is slowing. That being said, factors such as screen use, wearing of contact lenses, an ageing population that sees more prevalence of dry eyes, as well as pollution and allergies, continue to ...

Dermatologicals is expected to register muted current value growth in Portugal in 2025, but it is still expected to be positive value growth. Development of increasingly specific and advanced products sustain value sales. Social media also increasingly plays a role in terms of messaging and in parti ...

Sleep aids is expected to register both healthy current value and volume growth in 2025. Across all demographics, there is rising demand for sleep aids, as factors such as stress drive growth. Clear messaging also supports value sales and brands advertise widely and are constantly looking to differe ...

Vitamins is expected to register a fall in volume sales in 2025, as the impetus from the pandemic peeters out. In addition, some consumers are switching to dietary supplements or fortified foods. Single vitamins, in particular, perform weakly, with the exception of vitamin B and vitamin D. Vitamin B ...

NRT smoking cessation aids is expected to register minimal current value and volume growth in Portugal in 2025. In October 2024, two new brands, Cuitvar and Xistab from Champamix, with both containing the active ingredient varenicline and containing no nicotine were approved for 37% reimbursement fr ...